Inkyu Park

23PUBLICATIONS
32CO-AUTHORS
Molecular targetsNanomaterialsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 11, 2026
Targeted immunomodulation with CD44-targeting nanovaccine enhances antitumor immunity in melanoma through TLR7/8 and TLR3 agonists.

|Sep 23, 2025
A multifunctional nanotheranostic: hyaluronic acid-squalene nanoclusters for radiosensitization, ferroptosis, and Mn/Fe-based dual MR imaging.

Raveena Nagareddy, Sahil Chahal, Shyam Vasvani

|Mar 20, 2025
Programable Prodrug Nanomodulator Targets Tumor Redox Homeostasis Imbalance to Amplify Disulfidptosis and Immunogenic Pyroptosis for Breast Tumor Immunotherapy.

Ayeskanta Mohanty, Adityanarayan Mohapatra, Woojin Yang

|Dec 26, 2024
Dual-Mechanism mRNA Delivery via Fluorinated-Sorbitol Polyplexes: Enhancing Cellular Uptake and Endosomal Escape for COVID-19 Vaccination.

Arathy Vasukutty, Sahil Chahal, Kyung-Hwa Lee

|Sep 28, 2024
Inorganic Nanomedicine-Mediated Ferroptosis: A Synergistic Approach to Combined Cancer Therapies and Immunotherapy.

Adityanarayan Mohapatra, Ayeskanta Mohanty, In-Kyu Park

|Jul 23, 2024
Reactive oxygen species driven prodrug-based nanoscale carriers for transformative therapies.

Shyam Vasvani, Arathy Vasukutty, Rizia Bardhan

Pageof 4

Frequent Collaborators

6 joint publications

Saji Uthaman

5 joint publications

Adityanarayan Mohapatra

3 joint publications

Rizia Bardhan

3 joint publications

Vasvani Shyam Hareshkumar